Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT

PHASE3CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Neurocysticercosis
Interventions
DRUG

7 days of albendazole 15 mg/kg/day

group A will receive 7 days of oral albendazole 15 mg/kg/day

DRUG

28 days of albendazole 15 mg/kg/day

group B will receive 28 days of oral albendazole 15 mg/kg/day

Trial Locations (1)

110029

sheffali Gulati, New Delhi

All Listed Sponsors
lead

All India Institute of Medical Sciences

OTHER

NCT02243644 - Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT | Biotech Hunter | Biotech Hunter